Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gri Bio Inc (GRI)

Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)

GRI : 0.6890 (+7.82%)
GRI Bio, Inc. Reports $13.9 Million in Gross Proceeds and Provides Update on GRI-0621 Phase 2a Study for IPF Treatment

GRI Bio raised $13.9 million, extending its cash runway for GRI-0621's Phase 2a study in idiopathic pulmonary fibrosis.Quiver AI SummaryGRI Bio, Inc. announced it has raised $13.9 million in gross proceeds...

GRI : 0.6890 (+7.82%)
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis

GRI : 0.6890 (+7.82%)
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024

GRI : 0.6890 (+7.82%)
GRI Bio Announces Exercise of Warrants

GRI : 0.6890 (+7.82%)
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

GRI : 0.6890 (+7.82%)
GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis

GRI : 0.6890 (+7.82%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0099 (-1.00%)
GRI : 0.6890 (+7.82%)
MBRX : 2.83 (+5.99%)
XBIO : 4.01 (+0.57%)
AREC : 1.0800 (+1.89%)
CNSP : 0.1300 (+5.18%)
NVNO : 3.30 (-2.08%)
PALI : 2.44 (unch)

Barchart Exclusives

Recent Corn Rally Artificially Propped Up – What’s Next?
Corn prices appeared to have finally found a bottom from the summer sell-off. Speculators were short the market in record numbers until late August, when they began buying back contracts, convincing some that the harvest seasonal low may be in. Then, exports increased in the last few weeks, and prices rallied more. While the bearish fundamentals of 1.9 billion carry-out and the massive amount of unpriced corn still linger, there isn’t much hope for a significant price rally yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar